Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
InvestorsHub on MSN
Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer
Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing agreement with Pfizer (NYSE:PFE) covering its Matrix-M adjuvant technology. Under ...
JEE Advanced 2026 Syllabus: The Indian Institute of Technology (IIT) Roorkee, the conducting authority for JEE Advanced 2026, has published the detailed, topic-wise syllabus on its official website at ...
Enhancing the Mechanical Properties of Microgels through Interstitial Matrix Addition in 3D Printing
Microgels have excellent biocompatibility and tunable physicochemical properties but poor mechanical properties that severely limit their application. In this study, a strategy is developed to ...
You have to hand it to ASUS and its Republic of Gamers (ROG) division, it's not afraid to experiment with bold GPU designs. Following the launch of gold-themed Dhahab Edition graphics cards paying ...
Community driven content discussing all aspects of software development from DevOps to design patterns. The speed and efficiency of traditionally developed software applications is limited by the fact ...
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results